Table 1

Demographic features of the population and subgroups of patients with LE

nFemale, n (%)Age at onset (year), mean (SD)Course (month), mean (SD)Family history of LE, n (%)
Overall patients20971848 (88.1)30.4 (12.4)58.1 (67.1)106 (5.1)
 SLE18651690 (90.6)30.2 (12.2)58.6 (67.1)97 (5.2)
 CLE16481438 (87.3)29.8 (12.1)58.3 (66.4)84 (5.1)
 iCLE232158 (68.1)32.1 (13.7)53.6 (67.3)9 (3.9)
 SLE with LSM/CLE with SI14161280 (90.4)29.4 (11.8)59.1 (66.3)75 (5.3)
 SLE without LSM449410 (91.3)32.7 (13.0)57.0 (69.4)22 (4.9)
 CLE without SI232158 (68.1)32.1 (13.7)53.6 (67.3)9 (3.9)
 ACLE13301222 (91.9)29.0 (11.6)57.6 (64.2)68 (5.1)
 Localised ACLE387363 (93.8)29.3 (11.7)56.2 (60.1)20 (5.2)
 Generalised ACLE943859 (91.1)28.8 (11.5)58.1 (65.9)48 (5.1)
 SCLE160121 (75.6)31.1 (12.9)58.9 (68.1)10 (6.2)
 Annular SCLE9573 (76.8)30.9 (13.2)57.9 (70.3)4 (4.2)
 Papulosquamous SCLE7453 (71.6)30.9 (12.1)58.1 (62.5)7 (9.5)
 CCLE546437 (80.0)31.0 (13.0)65.1 (72.5)35 (6.4)
 DLE311224 (72.0)32.4 (13.6)64.8 (74.8)19 (6.1)
 CHLE262224 (85.5)29.4 (12.1)71.0 (73.9)14 (5.3)
 LEP4539 (86.7)28.6 (10.3)68.0 (63.2)5 (11.1)
  • ACLE, acute cutaneous lupus erythematosus; CCLE, chronic cutaneous lupus erythematosus; CHLE, chilblain lupus erythematosus; CLE, cutaneous lupus erythematosus; DLE, discoid lupus erythematosus; iCLE, isolated cutaneous lupus erythematosus; LE, lupus erythematosus; LEP, lupus erythematosus profundus; LSM, lupus erythematosus-specific cutaneous manifestation; SCLE, subacute cutaneous lupus erythematosus; SI, systemic involvement.